Print PDF

Sheppard Mullin Represents Permira in Sale of LSNE to PCI Pharma Services


A Sheppard Mullin Corporate team led by partners Andy Felner and Adam Shipley and associates Richard Hevier, David Rostowsky and Brett Uslaner are representing global private equity firm Permira in the sale of Lyophilization Services of New England, Inc. (“LSNE”), a premier contract manufacturing organization, to PCI Pharma Services (PCI), a leading pharmaceutical and biopharmaceutical global integrated solutions provider, as announced today.

The Sheppard Mullin deal team also included partners Michael Chan, Dmitriy Chelnitsky, David D’Amour, Shawn Fabian, Allison Fulton, Keith Gercken, Michael Leake, Alexis Robinson, Olivier Theard, and Dan Yannuzzi; and associates Aaron Duffy, Brian Egan, Mike Kim, Evan Lim, Alexander Rhim, Umar Sutter, and Michael Weisshar; and attorney Louise Dyble.

Click here to read the press release.


Jump to Page

By scrolling this page, clicking a link or continuing to browse our website, you consent to our use of cookies as described in our Cookie and Advertising Policy. If you do not wish to accept cookies from our website, or would like to stop cookies being stored on your device in the future, you can find out more and adjust your preferences here.